Dr. Robert Preissner, Ph.D.
Is a leading researcher and scientist in the fields of Structural Bioinformatics, Data Science, Pharmacogenomics
and Pharmacokinetics with more than 130 publications. Before his cutting-edge work with Drug-PIN, he served as the
Head of Science-IT at Charité University in Berlin, Germany, as well as other roles including Coordinator of the
Clinical Research Unit and Department Head of the Institute of Physiology. Outside of the university he contributes
to a number of organisations including the Clinical Research Unit at ECRC and BIH, the German Consortium for
Transnational Cancer Research (DKTK) and the National Consortium for Systems Immunology. Previously he led a
number of Departments in Molecular Biology, Bioinformatics and Allergy & Immunology in Germany as well as San Diego,
California (UCSD, La Jolla Institute).
A number of recent publications that have led to the development of the Drug-PIN solution include:
The target landscape of clinical kinase drugs - Science (IF: 37.205), 358(6367), 2018.
Pain prescription: an analysis of 500,000 discharge summaries. Curr. Drug Abuse Rev. 2018 (in press)
CardioScape mapping the cardiovascular funding landscape in Europe. Eur Heart J. (IF: 20.212) 10.1093/eurheartj/ehx106, 2018.
Drugs as habitable planets in the space of dark chemical matter. Drug Discov Today. (IF: 6.848) 23(3): 481-486, 2018.
SuperDRUG2: a one stop resource for approved/marketed drugs. Nucleic Acids Res. (IF: 11.561) 46: D1137-D1143, 2017.
WITHDRAWN: a resource for withdrawn and discontinued drugs. Nucleic Acids Res. (IF: 11.561) 44: D1080-6, 2016.
Dr. Robert Preissner, Ph.D. is a leading researcher and scientist in the fields of
Bioinformatics, Data Science, Pharmacogenomics and Pharmacokinetics with more